Copyright
©The Author(s) 2003.
World J Gastroenterol. Jun 15, 2003; 9(6): 1216-1219
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1216
Published online Jun 15, 2003. doi: 10.3748/wjg.v9.i6.1216
Table 1 Levels of Fhit expression in heptocellular carcinomas, para-neoplastic tissues and normal liver tissues
Table 2 Relationship between Fhit expression and clinicopathological indice
| Fhit score | ||||
| n | - | + | ++ | |
| Histological grade | ||||
| Grade I | 15 | 3 | 4 | 8 |
| Grade II | 39 | 12 | 9 | 18 |
| Grade III | 29 | 14 | 8 | 7 |
| Clinical stage | ||||
| Stage I-II | 37 | 4 | 4 | 29 |
| Stage III-IV | 46 | 25 | 17 | 4 |
| Size (mm) | ||||
| ≤ 50 | 39 | 10 | 7 | 22 |
| > 50 | 44 | 19 | 14 | 11 |
- Citation: Zhao P, Song X, Nin YY, Lu YL, Li XH. Loss of fragile histidine triad protein in human hepatocellular carcinoma. World J Gastroenterol 2003; 9(6): 1216-1219
- URL: https://www.wjgnet.com/1007-9327/full/v9/i6/1216.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i6.1216
